Polymyositis and dermatomyositis risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of polymyositis and dermatomyositis include environmental factors such as infection, malignancy, and drug toxicities from statins or immune checkpoint inhibitors. | |||
==Risk Factors== | ==Risk Factors== | ||
*Common risk factors in the development of polymyositis and dermatomyositis include .<ref name="pmid29579414">{{cite journal |vauthors=Adler BL, Christopher-Stine L |title=Triggers of inflammatory myopathy: insights into pathogenesis |journal=Discov Med |volume=25 |issue=136 |pages=75–83 |date=February 2018 |pmid=29579414 |doi= |url=}}</ref> | *Common risk factors in the development of polymyositis and dermatomyositis include environmental factors such as infection, malignancy, and drug toxicities from statins or immune checkpoint inhibitors.<ref name="pmid29579414">{{cite journal |vauthors=Adler BL, Christopher-Stine L |title=Triggers of inflammatory myopathy: insights into pathogenesis |journal=Discov Med |volume=25 |issue=136 |pages=75–83 |date=February 2018 |pmid=29579414 |doi= |url=}}</ref> | ||
===Common Risk Factors=== | ===Common Risk Factors=== | ||
*Common risk factors in the development of polymyositis and dermatomyositis include: | *Common risk factors in the development of polymyositis and dermatomyositis include: | ||
Revision as of 15:51, 5 April 2018
|
Polymyositis and dermatomyositis Microchapters |
|
Differentiating Polymyositis and dermatomyositis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polymyositis and dermatomyositis risk factors On the Web |
|
American Roentgen Ray Society Images of Polymyositis and dermatomyositis risk factors |
|
Risk calculators and risk factors for Polymyositis and dermatomyositis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Common risk factors in the development of polymyositis and dermatomyositis include environmental factors such as infection, malignancy, and drug toxicities from statins or immune checkpoint inhibitors.
Risk Factors
- Common risk factors in the development of polymyositis and dermatomyositis include environmental factors such as infection, malignancy, and drug toxicities from statins or immune checkpoint inhibitors.[1]
Common Risk Factors
- Common risk factors in the development of polymyositis and dermatomyositis include:
- Viral infections such as:
- Coxsackie B virus
- Parvovirus
- Enterovirus
- Human T-cell lymphotropic virus (HTLV-1)
- Human immunodeficiency virus (HIV)
- Epstein-Barr virus (EBV)
- Adenovirus
- Influenza
- Malignancy such as:
- Ovarian
- Lung
- Gastric
- Colorectal
- Pancreatic
- Non-Hodgkin’s lymphoma
- Drugs such as:
- Statins
- Immune checkpoint inhibitors such as:
- Ipilimumab
- Pembrolizumab
- Interferon-alpha
- IL-2 therapy
- Viral infections such as:
Less Common Risk Factors
- Less common risk factors in the development of polymyositis and dermatomyositis include: